Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Supporters urge Senate Health & Welfare to add trigger language so FDA‑approved psilocybin therapy can be available to patients
Summary
Witnesses asked the Senate committee to add language to H.611 that would automatically align Vermont law with federal scheduling decisions so FDA‑approved psilocybin therapies can be prescribed and administered in medical settings without delay, citing veteran and mental‑health needs.
Supporters of a proposed amendment to H.611 told the Senate Health & Welfare Committee on April 1 that Vermont should adopt a “trigger” mechanism so FDA‑approved psilocybin therapies can be prescribed in state medical settings without avoidable delay.
Tess Betler, Associate Director of Government Affairs at Compass Pathways, asked the committee to include language that “will automatically align Vermont law with federal scheduling decisions, allowing FDA approved psilocybin therapies to be prescribed and administered in a medical setting in Vermont without delay once approved and rescheduled.” She said investigational COMP360 has shown promising clinical…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
